We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHSC Regulatory News (PHSC)

Share Price Information for PHSC (PHSC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 22.00
Bid: 21.00
Ask: 23.00
Change: 0.00 (0.00%)
Spread: 2.00 (9.524%)
Open: 22.00
High: 22.00
Low: 22.00
Prev. Close: 22.00
PHSC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-Year Report

23 Nov 2021 07:00

PHSC Plc - Half-Year Report

PHSC Plc - Half-Year Report

PR Newswire

London, November 22

23 November 2021

PHSC PLC

(“PHSC”, the “Company” or the “Group”)

Unaudited Interim Results for the six months ended 30 September 2021

PHSC (AIM: PHSC), a leading provider of health, safety, hygiene and environmental consultancy services and security solutions to the public and private sectors, is pleased to announce its unaudited interim results for the six month period ended 30 September 2021.

GROUP CHIEF EXECUTIVE OFFICER’S STATEMENT

Financial Highlights

Group revenue excluding grant funding of £1.719m (H1 FY21: £1.377m). EBITDA of £163k (includes £29k of grant funding) (H1 FY21: £182k including £316k of grant funding). Lower EBITDA reflects a reduction of £287k in grant funding over the period. Adjusted EBITDA, excluding all grant funding, of £134k (H1 FY21: £134k loss). Earnings per share of 0.78p (H1 FY21: 0.83p). Successful share buyback programme completed during the period, as previously announced. Cash of £902k after £325k cost of the share buyback programme (H1 FY21: £1.0m). Net asset value (unaudited) of £4.7m (H1 FY21: £5.1m). Pro-forma net asset value (unaudited) per share of 35.9p, compared to a mid-market share price as at market close on 30 September 2021 of 22p. Interim dividend declared of 0.5p per ordinary share.

Operational Highlights and Business Outlook

In Q2 2021, the majority of the restrictions imposed by the UK Government in response to the COVID-19 pandemic were lifted or relaxed, which led to an overall improvement in total revenue for H1 FY21 as clients began their own recovery programmes. The gradual return to more normal working conditions meant that the Group had progressively less reliance on the Government’s Coronavirus Job Retention Scheme (“CJRS”). This led to reduced grant receipts, down from approximately £316k in H1 FY21 to just below £30k for H1 FY22.

We continue to maintain a £50,000 banking facility with HSBC Bank plc which has been renewed for a further year to October 2022. We have not made any use of such facility and do not expect to have to do so.

Despite the reopening of retail premises, the Security Division has not returned to the level of pre-pandemic trading. This is due predominantly to the permanent closure of former key clients such as Debenhams, Peacocks and Edinburgh Woollen Mill. Another factor that impacts margins is the cost of transportation, with all security related products being shipped in from abroad. Carriage charges have risen, in some cases five-fold, and it is simply not possible to pass on and recover such increase from the end user where prices are built into existing contracts. The business has reduced its cost base by downsizing the warehousing and office space it occupies, and staffing levels are now as low as is practicable without adversely affecting the customer experience. Management continues to seek to secure additional business from existing clients, as well as new client wins.

The reopening of education and leisure facilities has resulted in a welcome return to profitable trading for the relevant subsidiaries in the Safety Division that specialise in such sectors.

Our subsidiary focused on the statutory examination of plant and equipment was largely unaffected by COVID-19, save where clients had closed their workplaces, as there was no derogation offered by the relevant authorities from the legal obligation to ensure safety of the plant concerned. However, since lockdown has been lifted, we have found that costs have risen considerably, particularly in the prices of accommodation and travel, which has adversely affected margins.

Our Systems Division has bounced back exceptionally well from the enforced suspension of many of its activities, including the delivery of public training courses. Notably, the new revenue stream from our ‘UK Responsible Person’ (“UKRP”) service continues to increase. This service provides a portal to enable clients in the European Union (“EU”) medical device sector to supply the UK marketplace. Further growth is anticipated in the number of clients using this service.

General safety consultancy and training sales have shown a marked improvement, although EBITDA has reduced across the Safety Division as a whole due to the significantly lower income from CJRS funding. Further details are provided by way of the segmental analysis below showing the performance of individual subsidiaries.

The Board is generally satisfied with the Group’s performance at this stage of its COVID-19 recovery programme and is confident that further progress can be achieved over the remainder of the financial year.

Dividend

The Board is confident that the Group will remain profitable and has sufficient cash reserves to enable the payment of an interim dividend. Accordingly, the Board has decided to declare an interim dividend of 0.5p per ordinary share, to be paid on 21 January 2022, to those shareholders on the register of members on 24 December 2021.

As in previous years, the recommendation by the Board of any final dividend will be subject to the Group’s full year performance and the outlook at that time.

Cash Flow

Cash at bank on 30 September 2021 stood at £902k compared to approximately £1m at the same time last year. As indicated, the lower balance at the interim stage reflects the utilisation of £325k on the Company’s successful share buyback programme implemented during the period.

The cash reserves are sufficient to service all requirements arising in the normal course of the Group’s business and in relation to the proposed dividend. Whilst the Board has not currently committed to any additional calls on the Company’s cash, it is anticipated that a potential further share buyback programme, utilising the authority granted by the relevant special resolution passed at the 2021 Annual General Meeting, will be duly considered by the Board prior to the end of the financial year and announced as appropriate.

Discrete Performance by Trading Subsidiaries

Profit/loss figures for individual subsidiaries below are stated before tax and inter-company charges (including the costs of operating the parent plc which are recovered through management charges levied on, and dividends received from, trading subsidiaries), interest paid and received, depreciation and amortisation. Invoiced sales do not include CJRS grant funding, but such income is taken into account when calculating profit/loss figures. The net reduction of £287k in grant funding is the reason that most of the Company’s subsidiaries show lower EBITDA despite higher sales revenue.

Inspection Services (UK) Limited

Invoiced sales of £94,392 yielding a profit of £10,923 (H1 FY21: £113,807 and £25,471).

Personnel Health and Safety Consultants Limited

Invoiced sales of £607,906 yielding a profit of £198,579 (H1 FY21: £381,531 and £223,591).

RSA Environmental Health Limited

Invoiced sales of £130,953 resulting in a profit of £15,646 (H1 FY21: £100,123 and £30,686).

Quality Leisure Management Limited

Invoiced sales of £137,281 resulting in a profit of £37,500 (H1 FY21: £90,369 and £40,342).

QCS International Limited

Invoiced sales of £356,968 yielding a profit of £113,668 (H1 FY21: £196,533 and £46,705).

B2BSG Solutions Limited

Invoiced sales of £391,729 resulting in a loss of £16,738 (H1 FY21: £495,228 and £4,394 loss).

For further information please contact:

PHSC plcStephen King Tel: 01622 717 700Stephen.king@phsc.co.ukwww.phsc.plc.uk

Strand Hanson Limited (Nominated Adviser) Tel: 020 7409 3494James Bellman/Matthew Chandler

Novum Securities Limited (Broker) Tel: 020 7399 9427Colin Rowbury

About PHSC

PHSC, through its trading subsidiaries, Personnel Health & Safety Consultants Ltd, RSA Environmental Health Ltd, QCS International Ltd, Inspection Services (UK) Ltd and Quality Leisure Management Ltd, provides a range of health, safety, hygiene, environmental and quality systems consultancy and training services to organisations across the UK. In addition, B2BSG Solutions Ltd offers innovative security solutions including tagging, labelling and CCTV.

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018.

Group Statement of Comprehensive Income Six months ended Six months endedYear ended
30 Sept 2130 Sept 2031 Mar 21
NoteUnauditedUnauditedAudited
£’000£’000£’000
Continuing operations
Revenue31,7191,3773,290
Cost of sales(888)(767)(1,765)
Gross profit8316101,525
Administrative expenses(727)(775)(1,528)
Goodwill impairment2--(250)
Government grants29316441
Other income--1
Profit from operations133151189
Finance income-11
Profit before taxation133152190
Corporation tax expense(27)(31)(102)
Profit for the period after tax attributable to owners of parent310612188
Total comprehensive income attributable to owners of the parent 10612188
Basic and diluted earnings per share for profit after tax from continuing operations attributable to the equity holders of the Group during the period50.78p0.83p0.60p

Group Statement of Financial Position30 Sept 2130 Sept 2031 Mar 21
UnauditedUnauditedAudited
Note£’000£’000£’000
Non-current assets
Property, plant and equipment4500565530
Goodwill3,0283,2783,028
Deferred tax asset2202
3,5303,8633,560
Current assets
Inventories252263260
Trade and other receivables686753590
Cash and cash equivalents9021,0031,237
1,8402,0192,087
Total assets35,3705,8825,647
Current liabilities
Trade and other payables460571518
Right of use lease liability283432
Current corporation tax payable1157188
603676638
Non-current liabilities
Right of use lease liability265439
Deferred taxation liabilities515251
7710690
Total liabilities680782728
Net assets4,6905,1004,919
Capital and reserves attributable to equity holders of the Group
Called up share capital1,3081,4681,468
Share premium account1,9161,9161,916
Merger relief reserve134134134
Other reserves304144144
Retained earnings1,0281,4381,257
4,6905,1004,919

Group Statement of Changes in Equity
Share CapitalShare PremiumMerger Relief ReserveOther Reserves *Retained Earnings Total
£’000£’000£’000£’000£’000£’000
Balance at 1 April 20211,4681,9161341441,2574,919
Profit for the period attributable to equity holders----106106
Purchase of Treasury shares(160)--160(325)(325)
Cost of share buyback----(10)(10)
Balance at 30 September 20211,3081,9161343041,0284,690
Balance at 1 April 20201,4681,9161341441,3174,979
Profit for the period attributable to equity holders----121121
Balance at 30 September 20201,4681,9161341441,4385,100

* Other reserves represent the merger relief reserve and Treasury shares held by the Group.

Group Statement of Cash Flows Six months Six monthsYear
endedendedended
30 Sept 2130 Sept 2031 Mar 21
UnauditedUnauditedAudited
£’000£’000£’000
Cash flows generated from operating activities
Cash generated from operations17264702
Tax paid--(37)
Net cash generated from operating activities17264665
Cash flows used in investing activities
Purchase of property, plant and equipment-(2)(9)
Disposal of fixed assets--4
Interest received-11
Net cash used in investing activities-(1)(4)
Cash flows used in financing activities
Payments on right of use assets(17)(16)(33)
Share buyback(335)--
Dividends paid to Group shareholders--(147)
Net cash used in financing activities(352)(16)(180)
Net increase in cash and cash equivalents(335)247481
Cash and cash equivalents at beginning of period1,237756756
Cash and cash equivalents at end of period9021,0031,237
Notes to the cash flow statement
Cash generated from operations
Operating profit - continuing operations133151189
Depreciation charge303066
Goodwill impairment--250
Loss on sale of fixed assets--2
Decrease in inventories814
Decrease/(increase) in trade and other receivables(96)133296
Decrease in trade and other payables(58)(51)(105)
Cash generated from operations17264702

Notes to the Financial Statements

1. Basis of preparation

These condensed consolidated financial statements are presented on the basis of International Financial Reporting Standards (IFRS) as adopted by the European Union and interpretations issued by the International Financial Reporting Interpretations Committee (IFRIC) and have been prepared in accordance with the AIM Rules for Companies and the Companies Act 2006, as applicable to companies reporting under IFRS.

The financial information contained in this announcement, which has not been audited, does not constitute statutory accounts as defined by Section 434 of the Companies Act 2006. The Group’s statutory financial statements for the year ended 31 March 2021, prepared under IFRS, have been filed with the Registrar of Companies. The auditor’s report for the 2021 financial statements was unqualified and did not contain a statement under Section 498 (2) or (3) of the Companies Act 2006.

The same accounting policies and methods of computation are followed within these interim financial statements as adopted in the most recent annual financial statements.

Impairment of goodwill

The Board has considered the carrying value of goodwill and is satisfied that the assumptions made at the time of the last adjustment remain valid. Although a half year loss has been incurred by the Security Division, the effect of the cost reduction programme implemented in Q1 2021 should improve the financial year end position. The longer-term outlook presently remains stable and an impairment charge in these interim financial statements is not therefore considered necessary but will be reassessed at the year end.

Government grants

Government grants represent amounts receivable in relation to the CJRS. The grants have been recognised in the period to which the costs relate.

 2. Exceptional Administrative Expenses

Six months endedSix months endedYear ended
30 Sept 2130 Sept 2031 Mar 21
UnauditedUnauditedAudited
Impairment of PHSC plc’s investment in£’000£’000£’000
B2BSG Solutions Limited--200
RSA Environmental Health Limited--50

3. Segmental Reporting

Six months endedSix months endedYear ended
30 Sept 2130 Sept 2031 Mar 21
UnauditedUnauditedAudited
Revenue£’000£’000£’000
Security division: B2BSG Solutions Ltd3924951,136
3924951,136
Health & Safety division
Inspection Services (UK) Ltd94114214
Personnel Health & Safety Consultants Ltd608382969
Quality Leisure Management Ltd13790235
RSA Environmental Health Ltd131100235
9706861,653
Systems division: QCS International Ltd357196501
Total revenue1,7191,3773,290
Profit/(loss) after taxation, before management charge
Security division: B2BSG Solutions Ltd(13)(1)3
Health & Safety division
Inspection Services (UK) Ltd61827
Personnel Health & Safety Consultants Ltd166183409
Quality Leisure Management Ltd303385
RSA Environmental Health Ltd132551
215259572
Systems division: QCS International Ltd8733104
Holding company: PHSC plc(183)(170)(341)
106121338
Goodwill impairment--(250)
Total Group profit after taxation10612188

30 Sept 2130 Sept 2031 Mar 21
UnauditedUnauditedAudited
Total assets£’000£’000£’000
Security division: B2BSG Solutions Ltd292411320
Safety division
Inspection Services (UK) Ltd108176121
Personnel Health & Safety Consultants Ltd470581377
Quality Leisure Management Ltd166210168
RSA Environmental Health Limited584637595
1,3281,6041,261
Systems division: QCS International Ltd337320253
Holding company: PHSC plc4,1844,3224,584
6,1416,6576,418
Adjustment of goodwill(773)(775)(773)
Adjustment of deferred tax2-2
Total assets5,3705,8825,647

4. Property, plant and equipment

30 Sept 2130 Sept 2031 Mar 21
UnauditedUnauditedAudited
£’000£’000£’000
Cost or valuation
Brought forward928949949
Additions-28
Disposals--(29)
Carried forward928951928
Depreciation
Brought forward398356356
Charge303065
Disposals--(23)
Carried forward428386398
Net book value500565530

5. Earnings per share

The calculation of the basic earnings per share is based on the following data.

Six months endedSix months ended Year ended
30 Sept 2130 Sept 2031 Mar 21
UnauditedUnauditedAudited
£’000£’000£’000
Earnings
Continuing activities10612188
Number of shares30 Sept 2130 Sept 2031 Mar 21
Weighted average number of shares for the purpose of basic earnings per share13,646,49714,667,25714,667,257
Date   Source Headline
12th Apr 20244:05 pmPRNUpdate re: Director's Shareholding
3rd Apr 20244:50 pmPRNHolding(s) in Company
2nd Apr 202411:51 amPRNReplacement RNS: Transaction in Own Shares and Completion of Buyback Programme
2nd Apr 20247:00 amPRNTransaction in Own Shares and Completion of Buyback Programme
28th Mar 20247:00 amPRNTransaction in Own Shares
19th Mar 20247:00 amPRNCommencement of Further Share Buyback Programme
29th Nov 20232:26 pmPRNDirector Dealing
16th Nov 20237:00 amPRNHalf-year Report
29th Sep 20233:45 pmPRNCancellation of Treasury Shares
28th Sep 20236:14 pmPRNUpdate re Result of Annual General Meeting
28th Sep 202311:00 amPRNResults of AGM and Trading Update
24th Aug 20233:39 pmPRNHolding(s) in Company
24th Aug 20232:34 pmPRNHolding(s) in Company
24th Aug 20237:00 amPRNTransaction in Own Shares and Completion of Buyback Programme
23rd Aug 202311:15 amPRNTransaction in Own Shares
15th Aug 20237:00 amPRNCommencement of Further Share Buyback Programme
16th Mar 20227:00 amPRNCompletion of Buyback Programme
9th Mar 20225:15 pmPRNTransaction in Own Shares
1st Mar 20225:15 pmPRNHolding(s) in Company
25th Feb 20229:00 amPRNTransaction in Own Shares
16th Feb 20223:15 pmPRNTransaction in Own Shares
1st Feb 20227:00 amPRNTransaction in Own Shares
21st Jan 20227:00 amPRNCommencement of Further Share Buyback Programme
23rd Nov 20217:00 amPRNHalf-Year Report
30th Sep 20213:44 pmPRNResult of AGM
29th Jul 20219:00 amPRNFinal Results for the year ended 31 March 2021
17th Jun 20217:00 amPRNCompletion of Buyback Programme
10th Jun 20217:00 amPRNTransaction in Own Shares
7th Jun 20217:00 amPRNHolding(s) in Company
3rd Jun 20217:00 amPRNTransaction in Own Shares
26th May 20217:00 amPRNTransaction in Own Shares
13th May 20217:05 amPRNCommencement of Share Buyback Programme
13th May 20217:00 amPRNTrading Update
24th Nov 20207:00 amPRNInterim Results
21st Oct 20201:07 pmPRNDirector/PDMR Shareholding
30th Sep 202012:04 pmPRNResult of AGM
24th Aug 20209:19 amPRNDirector's Dealing
20th Aug 20203:47 pmPRNHolding(s) in Company
20th Aug 20207:00 amPRNFinal Results
13th May 20207:00 amPRNTrading Update and Commentary on COVID-19 Impact
17th Feb 20205:54 pmPRNDirector's Dealing
2nd Dec 20191:00 pmPRNHalf-year Report
30th Sep 201912:24 pmPRNResult of AGM
30th Sep 20197:00 amPRNAGM Statement
20th Aug 20198:29 amPRNFinal Payment Dividend Date
19th Aug 20193:49 pmPRNDirector's Dealing
19th Aug 20197:00 amPRNAnnual Financial Report
7th Jun 20197:00 amPRNTrading Update
14th Dec 20182:31 pmPRNDirector's Dealing
5th Dec 20187:00 amPRNHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.